Interim report January – September 2026 Sweco AB (publ)

Sweco reported its strongest third quarter to date, with net sales up 7% to SEK 7.6 billion and organic growth of 2% adjusted for calendar effects. EBITA rose 10% on the same adjusted basis to SEK 786 million, lifting the margin to 10.3% in a seasonally challenging quarter. Management said market demand was consistent with previous quarters, while AI development and M&A progressed according to plan.

Analysis

The useful signal is execution rather than a demand inflection: stronger profitability amid broadly unchanged markets may indicate better utilization, pricing, or cost control. That supports confidence in earnings resilience, but does not by itself justify a sector-wide growth re-rating. The gap between reported and calendar-adjusted organic sales growth should be decomposed into acquisition contribution, currency, and other effects before treating headline growth as repeatable.

Over the next few days, the stock’s reaction will depend more on expectations and valuation than on the quarter in isolation; the supplied data do not establish either. Over 1–3 months, watch organic growth, utilization/backlog, and whether margin improvement persists as project mix changes. Over 6–18 months, AI could improve consultant productivity and delivery economics, but clients may capture some savings through lower fees; M&A can add capacity and growth while raising integration and capital-allocation risk. A reversal in margins alongside weak organic growth would undermine the execution thesis. Competitors such as AFRY and Arcadis face similar utilization and pricing dynamics, so relative performance may be more informative than the sector’s absolute move.

Key Decisions for Investors

• Treat the quarter as a modest positive for SWEC.B’s earnings-quality thesis, not evidence of accelerating end-market demand. Avoid chasing a sharp opening gap without checking the market reaction against the company’s organic growth and margin trajectory.
• Watch the next update for organic growth excluding acquisitions and currency, backlog/utilization, and cash conversion. If margins retreat while organic growth remains subdued, reassess the view that execution can offset weak demand.
• For a relative-value watchlist, compare SWEC.B with AFRY and Arcadis on organic growth, margin direction, and valuation; do not initiate a pair trade without current relative valuation and consensus data.
• Keep AI and M&A as medium-term monitoring items, not standalone catalysts: verify measurable productivity gains and acquisition returns before attributing durable earnings growth to either.